Isatis tinctoria L.-derived Petroleum Ether Extract Mediates Anti-inflammatory Effects via Inhibition of Interleukin-6, Interleukin-33 and Mast Cell Degranulation

Acta Derm Venereol. 2020 May 11;100(10):adv00131. doi: 10.2340/00015555-3476.

Abstract

Isatis tinctoria L. (woad) has been used in medicine for centuries and has demonstrated anti-inflammatory effects. However, to date, no well-defined extracts with precise analysis of active substances have been developed. The aim of this study was to develop novel extracts of Isatis tinctoria L., and to characterize their active ingredients and anti-inflammatory properties. Various extracts of Isatis tinctoria L. were analysed for their active ingredients, and screened for anti-inflammatory effects using cyclooxygenase-2 activity assays. A petroleum ether extract was found to have the best effects, and was tested in a mouse model of acute allergic contact dermatitis. In the mouse model the petroleum ether extract resulted in significantly reduced ear swelling, oedema and inflammatory cell density. In mouse skin and human keratinocyte cultures, petroleum ether extract inhibited pro-inflammatory cytokine expression. Furthermore, human mast cell degranulation was significantly inhibited in LAD2 cell cultures. In conclusion, novel woad extracts were developed and shown to have anti-inflammatory properties in a contact hypersensitivity animal model and human keratinocytes. The production of such extracts and further characterization of their specific properties will enable determination of their potential dermatological effects in the treatment of inflamed and irritated skin.

Keywords: Isatis tinctoria L; anti-inflammatory agent; atopic eczema; contact dermatitis; pruritus.

MeSH terms

  • Administration, Topical
  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / immunology
  • Anti-Inflammatory Agents / therapeutic use*
  • Cells, Cultured
  • Dermatitis, Allergic Contact / drug therapy*
  • Dermatitis, Allergic Contact / immunology
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / immunology
  • Dermatologic Agents / therapeutic use
  • Disease Models, Animal
  • Ear
  • Humans
  • Interleukin-1beta / antagonists & inhibitors
  • Interleukin-1beta / immunology
  • Interleukin-33 / antagonists & inhibitors
  • Interleukin-33 / immunology
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-6 / immunology
  • Isatis*
  • Keratinocytes / drug effects
  • Keratinocytes / immunology
  • Mast Cell Stabilizers / administration & dosage
  • Mast Cell Stabilizers / immunology
  • Mast Cell Stabilizers / therapeutic use
  • Mast Cells / drug effects
  • Mast Cells / immunology
  • Mice
  • Phytotherapy*
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Skin / drug effects
  • Skin / immunology
  • Skin / pathology

Substances

  • Anti-Inflammatory Agents
  • Dermatologic Agents
  • Interleukin-1beta
  • Interleukin-33
  • Interleukin-6
  • Mast Cell Stabilizers
  • Plant Extracts